Layer 1

Accord launches 'cost saving' ADHD generic drug

Sponsored

Generic manufacturer Accord (formerly Actavis) has launched Delmosart prolonged-release methylphenidate tablets.

The schedule two controlled drug is used to treat attention deficit hyperactivity disorder (ADHD) in children aged six and over.

Delmosart is available in 18mg, 27mg, 36mg and 54mg tablets in pack sizes of 30, the manufacturer said. The different strengths have a trade price of £15.59, £18.41, £21.23 and £36.81 respectively.

Jonathan Wilson, Accord UK managing director, said the company is “committed” to offering a “market competitive price to both pharmacists and the NHS".

“Having listened to our customers’ needs, we are ow offering further potential cost savings to the NHS with the addition of Delmosart to our extensive range of products,” Mr Wilson said.

Accord products are available through all major wholesalers or directly from Accord.

To order, contact 0800 731 0370

0 Comments
Question: 
Will you order this product?
Login or register to post comments

Job of the week

Pre-registration Pharmacists 2021
London (South), London (Greater)
Competitive package